twoXAR
2014
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Grant
LATEST DEAL TYPE
$225K
LATEST DEAL AMOUNT
7
INVESTORS
Description
Operator of an artificial intelligence-driven drug discovery company intended to build a pipeline of therapeutic candidates. The company leverages a computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships, providing clients with faster, cheaper and more accurate than traditional wet-lab based approaches.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Biotechnology
Primary Office
- 883 North Shoreline Boulevard
- Suite A100
- Mountain View, CA 94043
- United States
+1 (650) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore twoXAR’s full profile, request a free trial.
twoXAR Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 28-Nov-2018 | $225K | 000.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 19-Mar-2018 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 2. Seed Round | 06-Nov-2015 | $4.31M | $4.31M | 000.00 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | 24-Jun-2015 | Completed | Generating Revenue |
twoXAR Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
twoXAR Competitors (28)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verge Genomics | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Private Equity-Backed | Princeton, NJ | 000 | 0000 | 000000000 | 0000 |
| 000000000000 | Private Equity-Backed | London, United Kingdom | 000 | 00000 | 0000000 0000 | 00000 |
| 00 000000000000 | Venture Capital-Backed | Guilford, CT | 00 | 0000 | 00000000000 | 0000 |
| 0000000 00000000 | Formerly VC-backed | London, United Kingdom | 0 | 00.000 | 000000&0 | 00.000 |
twoXAR Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | |||
| OS Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SoftBank Ventures Asia | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Andreessen Horowitz | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Stex25 | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
twoXAR Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »twoXAR Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andrew Radin | twoXAR | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Brian Moriarty | twoXAR | Chief Financial Officer & Board Member | 000 0000 | |
| Joonpyo Lee | SoftBank Ventures Asia | Board Member | 000 0000 | |
| Jorge Conde | Andreessen Horowitz | Board Member | 000 0000 |